Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dorine de Jong"'
Autor:
Colton Ladbury, Claire Hao, William Tyler Watkins, Sagus Sampath, Jeffrey Wong, Arya Amini, Karen Sokolov, Jekwon Yeh, Karine A. Al Feghali, Dorine de Jong, Arjun Maniyedath, Shervin Shirvani, Liana Nikolaenko, Matthew Mei, Alex Herrera, Leslie Popplewell, Lihua Elizabeth Budde, Savita Dandapani
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Purpose/objective(s)Bridging radiation therapy (bRT) is increasingly being utilized prior to chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL). It is unknown how the extent of cytoreduction during bRT impacts outcomes.Ma
Externí odkaz:
https://doaj.org/article/502c60fc675a43be8a7a55a5466af5ee
Autor:
Andrea Lancia, Gianluca Ingrosso, Beatrice Detti, Eleonora Festa, Elisabetta Bonzano, Flavia Linguanti, Federico Camilli, Niccolò Bertini, Salvatore La Mattina, Carolina Orsatti, Giulio Francolini, Elisabetta Maria Abenavoli, Lorenzo Livi, Cynthia Aristei, Dorine de Jong, Karine A. Al Feghali, Shankar Siva, Carlotta Becherini
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The therapeutic landscape of metastatic prostate cancer has undergone a profound revolution in recent years. In addition to the introduction of novel molecules in the clinics, the field has witnessed a tremendous development of functional imaging mod
Externí odkaz:
https://doaj.org/article/4601032046324b4ca2ee1ab20f0a5052
Autor:
Hong Yun Ma, Jeeban Das, Conor Prendergast, Dorine De Jong, Brian Braumuller, Jacienta Paily, Sophia Huang, Connie Liou, Anna Giarratana, Mahdie Hosseini, Randy Yeh, Kathleen M. Capaccione
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 11, Pp 9019-9038 (2023)
Since its first approval by the FDA in 2017, tremendous progress has been made in chimeric antigen receptor (CAR) T cell therapy, the adoptive transfer of engineered, CAR-expressing T lymphocyte. CAR T cells are all composed of three main elements: a
Externí odkaz:
https://doaj.org/article/1b711b66a8704b90866a18ab3019d17b
Autor:
Conor M. Prendergast, Kathleen M. Capaccione, Egesta Lopci, Jeeban P. Das, Alexander N. Shoushtari, Randy Yeh, Daniel Amin, Laurent Dercle, Dorine De Jong
Publikováno v:
Diagnostics, Vol 13, Iss 5, p 992 (2023)
Advanced melanoma is one of the deadliest cancers, owing to its invasiveness and its propensity to develop resistance to therapy. Surgery remains the first-line treatment for early-stage tumors but is often not an option for advanced-stage melanoma.
Externí odkaz:
https://doaj.org/article/c6207da9452f42fd88bb063267be58fd
Autor:
Laetitia Vercellino, Dorine de Jong, Roberta di Blasi, Salim Kanoun, Ran Reshef, Lawrence H. Schwartz, Laurent Dercle
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Chimeric antigen receptor (CAR) T-cells are a novel immunotherapy available for patients with refractory/relapsed non-Hodgkin lymphoma. In this indication, clinical trials have demonstrated that CAR T-cells achieve high rates of response, complete re
Externí odkaz:
https://doaj.org/article/db9e61d1ebaf4d8c94bfea1f2644af5d
Autor:
Laetitia Vercellino, Dorine de Jong, Laurent Dercle, Benoit Hosten, Brian Braumuller, Jeeban Paul Das, Aileen Deng, Antoine Moya-Plana, Camry A’Keen, Randy Yeh, Pascal Merlet, Barouyr Baroudjian, Mary M. Salvatore, Kathleen M. Capaccione
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1116 (2022)
Melanoma is a deadly disease that often exhibits relentless progression and can have both early and late metastases. Recent advances in immunotherapy and targeted therapy have dramatically increased patient survival for patients with melanoma. Simila
Externí odkaz:
https://doaj.org/article/71ad8c135df14d95b321905d1737d73f
Autor:
Isabelle Martins, Syed Qasim Raza, Laurent Voisin, Haithem Dakhli, Frédéric Law, Dorine De Jong, Awatef Allouch, Maxime Thoreau, Catherine Brenner, Eric Deutsch, Jean-Luc Perfettini
Publikováno v:
Biomedical Journal, Vol 40, Iss 3, Pp 133-140 (2017)
The present review summarizes recent experimental evidences about the existence of the non-cell-autonomous death entosis in physiological and pathophysiological contexts, discusses some aspects of this form of cell death, including morphological, bio
Externí odkaz:
https://doaj.org/article/c8fd160464524faa9fe18e45b5b1e979
Autor:
Ladbury, Colton, Claire Hao, Watkins, William Tyler, Sampath, Sagus, Jeffrey Wong, Amini, Arya, Sokolov, Karen, Jekwon Yeh, Al Feghali, Karine A., Dorine de Jong, Maniyedath, Arjun, Shirvani, Shervin, Nikolaenko, Liana, Matthew Mei, Herrera, Alex, Popplewell, Leslie, Budde, Lihua Elizabeth, Dandapani, Savita
Publikováno v:
Frontiers in Immunology; 2024, p1-13, 13p
Autor:
Dorine de Jong, Jeeban P. Das, Hong Ma, Jacienta Pailey Valiplackal, Conor Prendergast, Tina Roa, Brian Braumuller, Aileen Deng, Laurent Dercle, Randy Yeh, Mary M. Salvatore, Kathleen M. Capaccione
Publikováno v:
Cancers. 15:2855
Treatment of non-small cell lung cancer (NSCLC) has undergone a paradigm shift. Once a disease with limited potential therapies, treatment options for patients have exploded with the availability of molecular testing to direct management and targeted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::220a6d1e5ffcf6e2a1b85fcf7961171a
https://doi.org/10.3390/cancers15102855
https://doi.org/10.3390/cancers15102855
Autor:
Dorine de Jong, Laetitia Vercellino, Salim Kanoun, Lawrence H. Schwartz, Roberta Di Blasi, Laurent Dercle, Ran Reshef
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, 2021, 11 (16), pp.3998. ⟨10.3389/fonc.2021.664688⟩
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, 2021, 11 (16), pp.3998. ⟨10.3389/fonc.2021.664688⟩
Frontiers in Oncology, Vol 11 (2021)
International audience; Chimeric antigen receptor (CAR) T-cells are a novel immunotherapy available for patients with refractory/relapsed non-Hodgkin lymphoma. In this indication, clinical trials have demonstrated that CAR T-cells achieve high rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c0cf9944a5a75953310c3351b0d161
https://www.hal.inserm.fr/inserm-03925068/file/fonc-11-664688.pdf
https://www.hal.inserm.fr/inserm-03925068/file/fonc-11-664688.pdf
